A detailed history of Dimensional Fund Advisors LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 672,117 shares of RNA stock, worth $30.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
672,117
Previous 693,066 3.02%
Holding current value
$30.3 Million
Previous $28.3 Million 9.04%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$37.21 - $48.14 $779,512 - $1.01 Million
-20,949 Reduced 3.02%
672,117 $30.9 Million
Q2 2024

Aug 09, 2024

SELL
$22.73 - $40.85 $7.21 Million - $13 Million
-317,102 Reduced 31.39%
693,066 $28.3 Million
Q1 2024

May 10, 2024

SELL
$9.16 - $25.52 $4.48 Million - $12.5 Million
-489,605 Reduced 32.65%
1,010,168 $25.8 Million
Q4 2023

Feb 07, 2024

SELL
$4.87 - $9.37 $443,661 - $853,616
-91,101 Reduced 5.73%
1,499,773 $13.6 Million
Q3 2023

Nov 09, 2023

SELL
$6.3 - $11.35 $1.98 Million - $3.57 Million
-314,499 Reduced 16.51%
1,590,874 $10.1 Million
Q2 2023

Aug 09, 2023

BUY
$10.62 - $17.34 $6.76 Million - $11 Million
636,583 Added 50.17%
1,905,373 $21.1 Million
Q1 2023

May 12, 2023

BUY
$15.35 - $25.65 $5.32 Million - $8.89 Million
346,686 Added 37.6%
1,268,790 $19.5 Million
Q4 2022

Feb 09, 2023

BUY
$10.06 - $22.66 $2.64 Million - $5.94 Million
262,065 Added 39.7%
922,104 $20.5 Million
Q3 2022

Nov 10, 2022

BUY
$15.46 - $23.43 $2.32 Million - $3.51 Million
149,768 Added 29.35%
660,039 $10.8 Million
Q2 2022

Aug 12, 2022

BUY
$11.18 - $20.5 $1.54 Million - $2.82 Million
137,519 Added 36.89%
510,271 $7.41 Million
Q1 2022

May 13, 2022

BUY
$14.2 - $23.78 $2.46 Million - $4.12 Million
173,365 Added 86.95%
372,752 $6.88 Million
Q4 2021

Feb 09, 2022

BUY
$20.4 - $28.66 $2.29 Million - $3.21 Million
112,084 Added 128.39%
199,387 $4.74 Million
Q3 2021

Nov 12, 2021

BUY
$18.16 - $25.21 $1.59 Million - $2.2 Million
87,303 New
87,303 $2.15 Million

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.35B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.